glp-1 latest How medications are transforming diabetes and weight loss treatment GLP-1 News: Latest Updates on

Restlessness and anxiety can emerge, particularly in the first week as the body adjusts to heightened norepinephrine activity

Chronic Disease Management: Increased use of GLP-1 medications may reduce the incidence of diabetes-related hospitalizations by 10%15% and cardiovascular events by up to 20%, improving long-term population health outcomes

Therefore, FAS inhibition reduces hepatic steatosis and de novo lipogenesis [44]

If sweating persists beyond the first month or worsens unexpectedly, report it to your PlexusDx clinician

The reduced glycemic load of meals caused by GLP-1 is very similar to that seen when replacing a meal with a high glycemic index (GI) with that of a low GI [21] (See Fig